SCHEMBL24917581

SCHEMBL24917581

COCC1CCCN1CCF

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.46
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
ARG1 P05089 2/20 0.43
ARG2 P78540 2/20 0.43
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC1 Q13547 1/20 0.42
CASP3 P42574 3/20 0.39
CASP7 P55210 3/20 0.39
DRD1 P21728 1/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39
DRD3 P35462 1/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HRH3 Q9Y5N1 2/20 0.39
TLR7 Q9NYK1 1/20 0.39
TRPV6 Q9H1D0 1/20 0.36
VEGFA P15692 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540921 1.00 DRD2 (0.46) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL24272883 0.89 DRD2 (0.44) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL25542061 0.89 DRD2 (0.36) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL25541248 0.89 DRD2 (0.36) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL2826704 0.85 ARG1 (0.46) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL2826706 0.85 ARG1 (0.46) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL10064193 0.85 ARG1 (0.46) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL9289311 0.83 DRD2 (0.44) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL14207963 0.83 HDAC8 (0.46) DRD2HTR2AHTR2CARG1ARG2
SCHEMBL9288703 0.83 DRD2 (0.44) DRD2HTR2AHTR2CARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023225252-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF RAS THERAS, INC. (US) 2023-11-23 WO disclosed
WO-2023133183-A1 KRAS INHIBITORS THERAS, INC. (US) 2023-07-13 WO disclosed
WO-2023133181-A1 KRAS INHIBITORS THERAS, INC. (US) 2023-07-13 WO disclosed
WO-2023086383-A1 SELECT KRAS G12C INHIBITORS AND USES THEREOF 1200 PHARMA LLC (US) 2023-05-19 WO disclosed
WO-2023004102-A2 COMPOSITIONS AND METHODS FOR INHIBITION OF RAS THERAS, INC. (US) 2023-01-26 WO disclosed